These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20473919)

  • 1. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
    Shelton LM; Huysentruyt LC; Seyfried TN
    Int J Cancer; 2010 Nov; 127(10):2478-85. PubMed ID: 20473919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
    Mukherjee P; Augur ZM; Li M; Hill C; Greenwood B; Domin MA; Kondakci G; Narain NR; Kiebish MA; Bronson RT; Arismendi-Morillo G; Chinopoulos C; Seyfried TN
    Commun Biol; 2019; 2():200. PubMed ID: 31149644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.
    Wang SZ; Poore B; Alt J; Price A; Allen SJ; Hanaford AR; Kaur H; Orr BA; Slusher BS; Eberhart CG; Raabe EH; Rubens JA
    Clin Cancer Res; 2019 Oct; 25(19):5925-5936. PubMed ID: 31300448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer.
    Zhang GQ; Xi C; Ju NT; Shen CT; Qiu ZL; Song HJ; Luo QY
    J Endocrinol Invest; 2024 Aug; 47(8):1953-1969. PubMed ID: 38386265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.
    Rais R; Jančařík A; Tenora L; Nedelcovych M; Alt J; Englert J; Rojas C; Le A; Elgogary A; Tan J; Monincová L; Pate K; Adams R; Ferraris D; Powell J; Majer P; Slusher BS
    J Med Chem; 2016 Sep; 59(18):8621-33. PubMed ID: 27560860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonizing Bcl-2 family members sensitizes neuroblastoma and Ewing's sarcoma to an inhibitor of glutamine metabolism.
    Olsen RR; Mary-Sinclair MN; Yin Z; Freeman KW
    PLoS One; 2015; 10(1):e0116998. PubMed ID: 25615615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis.
    Pham K; Maxwell MJ; Sweeney H; Alt J; Rais R; Eberhart CG; Slusher BS; Raabe EH
    J Neuropathol Exp Neurol; 2021 Mar; 80(4):336-344. PubMed ID: 33712838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast.
    Willis RC; Seegmiller JE
    J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic resurgence of 6-diazo-5-oxo-l-norleucine (DON) through tissue-targeted prodrugs.
    Novotná K; Tenora L; Slusher BS; Rais R
    Adv Pharmacol; 2024; 100():157-180. PubMed ID: 39034051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory Effect of a Glutamine Antagonist on Proliferation and Migration of VSMCs via Simultaneous Attenuation of Glycolysis and Oxidative Phosphorylation.
    Park HY; Kim MJ; Lee S; Jin J; Lee S; Kim JG; Choi YK; Park KG
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A redox-responsive prodrug for tumor-targeted glutamine restriction.
    Prange CJ; Sayed NYB; Feng B; Goepfert C; Trujillo DO; Hu X; Tang L
    J Control Release; 2024 Apr; 368():251-264. PubMed ID: 38403173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines.
    Huber KR; Rosenfeld H; Roberts J
    Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of 6-diazo-5-oxo-L-norleucine (DON), a glutamine analogue, on cartilaginous differentiation in mouse limb buds in vitro.
    Aydelotte MB; Kochhar DM
    Differentiation; 1975 Oct; 4(2):73-80. PubMed ID: 1183764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of
    Lemberg KM; Vornov JJ; Rais R; Slusher BS
    Mol Cancer Ther; 2018 Sep; 17(9):1824-1832. PubMed ID: 30181331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells.
    Madden MZ; Ye X; Chi C; Fisher EL; Wolf MM; Needle GA; Bader JE; Patterson AR; Reinfeld BI; Landis MD; Hathaway ES; Muka JE; O'Neil RT; Karijolich J; Philip M; Rathmell JC
    J Immunol; 2023 Aug; 211(4):563-575. PubMed ID: 37341499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-asparaginase and 6-diazo-5-oxo-L-norleucine synergistically inhibit the growth of glioblastoma cells.
    Ohba S; Hirose Y
    J Neurooncol; 2020 Feb; 146(3):469-475. PubMed ID: 32020477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine.
    Potter MC; Baxter VK; Mathey RW; Alt J; Rojas C; Griffin DE; Slusher BS
    J Neurovirol; 2015 Apr; 21(2):159-73. PubMed ID: 25645378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.
    Sharma NS; Gupta VK; Garrido VT; Hadad R; Durden BC; Kesh K; Giri B; Ferrantella A; Dudeja V; Saluja A; Banerjee S
    J Clin Invest; 2020 Jan; 130(1):451-465. PubMed ID: 31613799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria.
    Gordon EB; Hart GT; Tran TM; Waisberg M; Akkaya M; Kim AS; Hamilton SE; Pena M; Yazew T; Qi CF; Lee CF; Lo YC; Miller LH; Powell JD; Pierce SK
    Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13075-80. PubMed ID: 26438846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer.
    Huysentruyt LC; Shelton LM; Seyfried TN
    Int J Cancer; 2010 Jan; 126(1):65-72. PubMed ID: 19536778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.